Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PORTERS FIVE FORCES
5.2 REGULATORY LANDSCAPE
5.3 TECHNOLOGICAL TRENDS
5.4 VALUE CHAIN ANALYSIS
5.5 PATENT ANALYSIS
5.6 COMPANY COMPARITIVE ANALYSIS
5.7 KEY STRATEGIC DECISIONS
6 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY OFFERING
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 INTEGRATED
6.2.2 STANDALONE
6.3 SERVICES
6.3.1 CONSULTING
6.3.2 TRAINING AND EDUCATION
6.3.3 IMPLEMENTATION
6.3.4 SUPPORT SERVICES
7 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY DEPLOYMENT MODEL
7.1 OVERVIEW
7.2 CLOUD-BASED
7.3 ON-PREMISE
8 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY THERAPEUTIC AREA
8.1 OVERVIEW
8.2 CHRONIC DISEASE MANAGEMENT
8.3 HEALTH AND WELLNESS
8.4 OTHERS
9 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY TYPE
9.1 OVERVIEW
9.2 WORKFLOW SOLUTIONS
9.2.1 PATIENT CONSENT SOLUTION
9.2.2 APPOINTMENT SCHEDULING
9.2.3 ONLINE SELF‑SCHEDULING
9.2.4 CHATBOT SCHEDULING
9.2.5 IVR SCHEDULING
9.2.6 PATIENT PORTAL SCHEDULING
9.2.6.1. VIRTUAL VISITS
9.2.6.2. RESPONSE CALLS
9.2.6.3. ACTIVITY TRACKING
9.2.6.4. POST-DIAGNOSIS COMMUNICATION
9.2.6.5. PATIENT EDUCATION
9.2.6.6. EVENT REMINDERS
9.2.6.7. HEALTH SURVEYS
9.2.6.8. POST-FEEDBACK PATIENT ENGAGEMENT
9.2.6.9. OTHERS
9.3 INFRASTRUCTURE SOLUTIONS
9.3.1 EHR AUGMENTATION
9.3.2 EHEALTH ADAPTOR SETS
9.3.3 MASTER PATIENT INDEX
9.3.4 HEALTHCARE PROVIDER DIRECTORY
9.3.5 TERMINOLOGY SERVER
9.3.6 OTHERS
10 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HEALTH MANAGEMENT
10.2.1 WOMEN’S HEALTH
10.2.2 MENTAL HEALTH
10.2.3 OTHERS
10.3 HOME HEALTH MANAGEMENT
10.3.1 MONITORING AND COMPLIANCE TOOLS
10.3.2 VIRTUAL CARE
10.3.3 SELF SERVICE SOLUTION
10.3.4 WALK IN CLINICS
10.4 SOCIAL & BEHAVIORAL MANAGEMENT
10.5 FITNESS MANAGEMENT
10.5.1 DAILY MEDICATION
10.5.2 CALORIE COUNT
10.5.3 EXERCISE AND STEP COUNT
10.6 FINANCIAL HEALTH MANAGEMENT
10.6.1 AUTOMATION AND DIGITALIZATION
10.6.2 PAYMENT STRUCTURING
10.6.3 INSURANCE COVERAGE
10.7 OTHERS
11 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY END USER
11.1 OVERVIEW
11.2 PROVIDERS
11.2.1 HOSPITALS
11.2.1.1. ACUTE CARE HOSPITALS
11.2.1.2. LONG-TERM CARE HOSPITALS
11.2.1.3. PSYCHIATRIC HOSPITALS
11.2.1.4. OTHERS
11.2.2 NURSING FACILITIES
11.2.3 CHILDREN'S CLINICS
11.2.4 MENTAL HEALTH FACILITIES
11.2.5 HOME HEALTH
11.2.6 REHABILITATION CENTERS
11.2.6.1. OUTPATIENT
11.2.6.2. INPATIENT
11.2.7 PSYCHIATRIC FACILITIES
11.2.8 PHARMACIES
11.2.9 OTHERS
11.3 PAYERS
11.3.1 PRIVATE
11.3.2 PUBLIC
11.4 OTHERS
12 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY PRICING STRUCTURE
12.1 OVERVIEW
12.2 ONE TIME LICENSE
12.3 SUBSCRIPTION
12.3.1 MONTHLY
12.3.2 ANNUAL
13 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY OPERATING DEVICE
13.1 OVERVIEW
13.2 WINDOW
13.3 MAC
13.4 LINUX
13.5 MOBILE
13.5.1 ANDROID
13.5.2 IPHONE AND IPAD
14 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, BY REGION
GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
14.2 EUROPE
14.2.1 GERMANY
14.2.2 FRANCE
14.2.3 U.K.
14.2.4 ITALY
14.2.5 SPAIN
14.2.6 RUSSIA
14.2.7 TURKEY
14.2.8 POLAND
14.2.9 DENMARK
14.2.10 SWEDEN
14.2.11 BELGIUM
14.2.12 NETHERLANDS
14.2.13 SWITZERLAND
14.2.14 REST OF EUROPE
14.3 ASIA PACIFIC
14.3.1 JAPAN
14.3.2 CHINA
14.3.3 SOUTH KOREA
14.3.4 INDIA
14.3.5 AUSTRALIA AND NEW ZEALAND
14.3.6 SINGAPORE
14.3.7 THAILAND
14.3.8 MALAYSIA
14.3.9 INDONESIA
14.3.10 PHILIPPINES
14.3.11 TAIWAN
14.3.12 VIETNAM
14.3.13 REST OF ASIA PACIFIC
14.4 SOUTH AMERICA
14.4.1 BRAZIL
14.4.2 ARGENTINA
14.4.3 COLOMBIA
14.4.4 REST OF SOUTH AMERICA
14.5 MIDDLE EAST AND AFRICA
14.5.1 SOUTH AFRICA
14.5.2 EGYPT
14.5.3 SAUDI ARABIA
14.5.4 U.A.E
14.5.5 ISRAEL
14.5.6 QATAR
14.5.7 KUWAIT
14.5.8 REST OF MIDDLE EAST AND AFRICA
14.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
15 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15.4 COMPANY SHARE ANALYSIS: EUROPE
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT & APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, SWOT AND DBMR ANALYSIS
17 GLOBAL PATIENT ENGAGEMENT TECHNOLOGY MARKET, COMPANY PROFILE
17.1 ALLSCRIPTS HEALTHCARE LLC
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 ADVANCEDMD, INC.
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 NUANCE
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 WEAVE
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 LUMA HEALTH
17.6 SOLUTIONREACH
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 OHMD, INC.
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 REVENUEWELL
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 UPDOX
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 RXNT
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 ATHENAHEALTH
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 NXGN MANAGEMENT, LLC
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 CISCO
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENTS
17.14 IBM
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 MODERNIZING MEDICINE
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 NEXUS CLINICAL LLC
17.16.1 COMPANY OVERVIEW
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 PROGNOCIS
17.17.1 COMPANY OVERVIEW
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENTS
17.18 NET HEALTH
17.18.1 COMPANY OVERVIEW
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 DOCVILLA
17.19.1 COMPANY OVERVIEW
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENTS
17.2 CARECLOUD
17.20.1 COMPANY OVERVIEW
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 MEND VIP, INC.
17.21.1 COMPANY OVERVIEW
17.21.2 REVENUE ANALYSIS
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENTS
17.22 KLARA TECHNOLOGIES, INC
17.22.1 COMPANY OVERVIEW
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 TATA CONSULTANCY SERVICES LIMITED
17.23.1 COMPANY OVERVIEW
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 CONCLUSION
19 QUESTIONNAIRE
20 ABOUT DATA BRIDGE MARKET RESEARCH
